Literature DB >> 14730577

Direct ampholyte-free liquid-phase isoelectric peptide focusing: application to the human serum proteome.

Zhen Xiao1, Thomas P Conrads, David A Lucas, George M Janini, Carl F Schaefer, Kenneth H Buetow, Haleem J Issaq, Timothy D Veenstra.   

Abstract

In this study, we utilized a multidimensional peptide separation strategy combined with tandem mass spectrometry (MS/MS) for the identification of proteins in human serum. After enzymatically digesting serum with trypsin, the peptides were fractionated using liquid-phase isoelectric focusing (IEF) in a novel ampholyte-free format. Twenty IEF fractions were collected and analyzed by reversed-phase microcapillary liquid chromatography (microLC)-MS/MS. Bioinformatic analysis of the raw MS/MS spectra resulted in the identification of 844 unique peptides, corresponding to 437 proteins. This study demonstrates the efficacy of ampholyte-free peptide autofocusing, which alleviates peptide losses in ampholyte removal strategies. The results show that the separation strategy is effective for high-throughput characterization of proteins from complex proteomic mixtures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730577     DOI: 10.1002/elps.200305700

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  11 in total

Review 1.  Immobilized pH gradient isoelectric focusing as a first-dimension separation in shotgun proteomics.

Authors:  Benjamin J Cargile; Joel R Sevinsky; Amal S Essader; James L Stephenson; Jonathan L Bundy
Journal:  J Biomol Tech       Date:  2005-09

2.  A systematic evaluation of chip-based nanoelectrospray parameters for rapid identification of proteins from a complex mixture.

Authors:  Ana Gabriela Pereira-Medrano; Alistair Sterling; Ambrosius P L Snijders; Kenneth F Reardon; Phillip C Wright
Journal:  J Am Soc Mass Spectrom       Date:  2007-06-30       Impact factor: 3.109

3.  High dynamic range characterization of the trauma patient plasma proteome.

Authors:  Tao Liu; Wei-Jun Qian; Marina A Gritsenko; Wenzhong Xiao; Lyle L Moldawer; Amit Kaushal; Matthew E Monroe; Susan M Varnum; Ronald J Moore; Samuel O Purvine; Ronald V Maier; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-05-09       Impact factor: 5.911

4.  Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

Authors:  Tao Liu; Wei-Jun Qian; Marina A Gritsenko; David G Camp; Matthew E Monroe; Ronald J Moore; Richard D Smith
Journal:  J Proteome Res       Date:  2005 Nov-Dec       Impact factor: 4.466

Review 5.  Human body fluid proteome analysis.

Authors:  Shen Hu; Joseph A Loo; David T Wong
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984

6.  Development of a Chip/Chip/SRM platform using digital chip isoelectric focusing and LC-Chip mass spectrometry for enrichment and quantitation of low abundance protein biomarkers in human plasma.

Authors:  Agnes Rafalko; Shujia Dai; William S Hancock; Barry L Karger; Marina Hincapie
Journal:  J Proteome Res       Date:  2011-12-27       Impact factor: 4.466

7.  Comparison of two-dimensional fractionation techniques for shotgun proteomics.

Authors:  James A Dowell; Dustin C Frost; Jiang Zhang; Lingjun Li
Journal:  Anal Chem       Date:  2008-08-05       Impact factor: 6.986

8.  Proteomics with a pinch of salt: a cyanobacterial perspective.

Authors:  Jagroop Pandhal; Phillip C Wright; Catherine A Biggs
Journal:  Saline Systems       Date:  2008-04-15

9.  Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine.

Authors:  Elisabeth Drucker; Kurt Krapfenbauer
Journal:  EPMA J       Date:  2013-02-25       Impact factor: 6.543

10.  Functional proteomics of barley and barley chloroplasts - strategies, methods and perspectives.

Authors:  Jørgen Petersen; Adelina Rogowska-Wrzesinska; Ole N Jensen
Journal:  Front Plant Sci       Date:  2013-03-18       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.